<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339650</id>
  <title nil="true"/>
  <common-name>2-(6-bromo-4-oxo-3-phenylquinazolin-2-yl)sulfanyl-n,n-bis(2-methylpropyl)acetamide</common-name>
  <description>2-(6-bromo-4-oxo-3-phenylquinazolin-2-yl)sulfanyl-n,n-bis(2-methylpropyl)acetamide is a chemical compound with the formula C24H28BrN3O2S. With an average molecular weight of 502.50 g/mol, 2-(6-bromo-4-oxo-3-phenylquinazolin-2-yl)sulfanyl-n,n-bis(2-methylpropyl)acetamide is a heavy molecule.</description>
  <cas>65263-21-0</cas>
  <pubchem-id>3049806</pubchem-id>
  <chemical-formula>C24H28BrN3O2S</chemical-formula>
  <weight>502.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T23:00:30Z</created-at>
  <updated-at type="dateTime">2026-08-30T23:00:30Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C)CN(CC(C)C)C(=O)CSC1=NC2=C(C=C(C=C2)Br)C(=O)N1C3=CC=CC=C3</moldb-smiles>
  <moldb-formula>C24H28BrN3O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C24H28BrN3O2S/c1-16(2)13-27(14-17(3)4)22(29)15-31-24-26-21-11-10-18(25)12-20(21)23(30)28(24)19-8-6-5-7-9-19/h5-12,16-17H,13-15H2,1-4H3</moldb-inchi>
  <moldb-inchikey>MFBVPSHZCASKMS-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">501.10856</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM335543</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-(6-bromo-4-oxo-3-phenylquinazolin-2-yl)sulfanyl-n,n-bis(2-methylpropyl)acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0290068</sync-id>
  <structure-inchikey>MFBVPSHZCASKMS-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40400000000000200000800000000800000000000000000080000000000000000000001000000020010004000000002084000000000000000000000000000080200000000000000000000000000000000020000000200000000000800010000200000000010000000000000000144000000400000100000040002000000001000000004040000000804000000000000004000000000100000000020000000000000000000000000000040000080000000000000000000000000000000000000008000000000000002000000100000000000000000000000020000200000000000000000040000101080040000000000400000000010000000040040000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAIQAAAIABBgBgAAAAAQMGAGAAAAAD
AQYAYAAAAAEDBgBgAAAAAgIHACgAAAADAwYAYAAAAAICBgBgAAAAAwEGAGAA
AAABAwYAYAAAAAEDBgAoAAAAAwQIACgAAAADAgYAYAAAAAICEAAgAAAAAgZA
KAAAAAMEB0AoAAAAAwMGQCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkAoAAAA
AwQGQGgAAAADAwEGQGgAAAADAwEjACAAAAABBkAoAAAAAwQIACgAAAADAgdA
KAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgA
AAADAwEGQGgAAAADAwELAAEAAQIAAQMAAwQABAUABQYABgcABggABAkgCQoo
AgkLAAsMAAwNAA0OaAwOD2gMDxBoDBARaAwREmgMEhNoDBMUaAwSFQAQFmgM
FhcoAhYYaAwYGSAZGmgMGhtoDBscaAwcHWgMHR5oDBgNaAwUD2gMHhloDEID
AAAABg0YFhAPDgYREhMUDxAGGhscHR4ZFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:40:05Z</structure-indexed-at>
</compound>
